Conversely, suppressing m6A levels via METTL3‐siRNA treatments suppressed SLC7A11 expression, allowing increased accrual of lipid ROS and consequent induced ferroptosis, thus preventing tumorigenesis of HB cancer cells and tumour growth in mice. This evidence concerns the gene SLC7A11 and cancer.